25 XP   0   0   10

Hwail Pharmaceutical Co.Ltd
Buy, Hold or Sell?

Let's analyse Hwail together

PenkeI guess you are interested in Hwail Pharmaceutical Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hwail Pharmaceutical Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hwail Pharmaceutical Co.Ltd

I send you an email if I find something interesting about Hwail Pharmaceutical Co.Ltd.

Quick analysis of Hwail (30 sec.)










What can you expect buying and holding a share of Hwail? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
45.2%

What is your share worth?

Current worth
₩2,713.85
Expected worth in 1 year
₩2,788.79
How sure are you?
71.0%

+ What do you gain per year?

Total Gains per Share
₩74.95
Return On Investment
4.7%

For what price can you sell your share?

Current Price per Share
₩1,601.00
Expected price per share
₩1,550 - ₩1,621
How sure are you?
50%

1. Valuation of Hwail (5 min.)




Live pricePrice per Share (EOD)

₩1,601.00

Intrinsic Value Per Share

₩12,489.91 - ₩14,941.84

Total Value Per Share

₩15,203.76 - ₩17,655.68

2. Growth of Hwail (5 min.)




Is Hwail growing?

Current yearPrevious yearGrowGrow %
How rich?$122.1m$128m-$4.5m-3.7%

How much money is Hwail making?

Current yearPrevious yearGrowGrow %
Making money$676k-$1.1m$1.7m263.8%
Net Profit Margin3.2%-5.1%--

How much money comes from the company's main activities?

3. Financial Health of Hwail (5 min.)




What can you expect buying and holding a share of Hwail? (5 min.)

Welcome investor! Hwail's management wants to use your money to grow the business. In return you get a share of Hwail.

What can you expect buying and holding a share of Hwail?

First you should know what it really means to hold a share of Hwail. And how you can make/lose money.

Speculation

The Price per Share of Hwail is ₩1,601. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hwail.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hwail, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,713.85. Based on the TTM, the Book Value Change Per Share is ₩18.74 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-32.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hwail.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.020.0%0.010.0%-0.020.0%0.000.0%0.010.0%
Usd Book Value Change Per Share-0.020.0%0.010.0%-0.020.0%0.050.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.020.0%0.010.0%-0.020.0%0.050.0%0.040.0%
Usd Price Per Share1.54-1.47-1.91-3.57-4.19-
Price to Earnings Ratio-19.46-15.29-8.37-49.76-75.13-
Price-to-Total Gains Ratio-70.34-60.54-88.64--132.30--65.17-
Price to Book Ratio0.81-0.78-1.00-2.30-3.40-
Price-to-Total Gains Ratio-70.34-60.54-88.64--132.30--65.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1207
Number of shares892
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.010.05
Usd Total Gains Per Share0.010.05
Gains per Quarter (892 shares)11.7046.68
Gains per Year (892 shares)46.80186.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10473722165177
20948444329364
3014013166494551
4018717888659738
50234225110823925
602812721329881112
7032831915411531299
8037436617713171486
9042141319914821673
10046846022116471860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%14.04.00.077.8%26.05.00.083.9%30.05.00.085.7%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%13.05.00.072.2%22.09.00.071.0%26.09.00.074.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%5.00.013.027.8%14.00.017.045.2%17.00.018.048.6%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%13.05.00.072.2%22.09.00.071.0%26.09.00.074.3%

Fundamentals of Hwail

About Hwail Pharmaceutical Co.Ltd

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 10:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hwail Pharmaceutical Co.Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hwail earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Hwail to the  industry mean.
  • A Net Profit Margin of -6.2% means that ₩-0.06 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is -6.2%. The company is making a loss. -1
  • The TTM is 3.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM3.2%-9.4%
TTM3.2%YOY-5.1%+8.3%
TTM3.2%5Y0.8%+2.4%
5Y0.8%10Y2.4%-1.6%
1.1.2. Return on Assets

Shows how efficient Hwail is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hwail to the  industry mean.
  • -1.0% Return on Assets means that Hwail generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is -1.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM0.5%-1.5%
TTM0.5%YOY-0.9%+1.4%
TTM0.5%5Y0.2%+0.4%
5Y0.2%10Y0.5%-0.3%
1.1.3. Return on Equity

Shows how efficient Hwail is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hwail to the  industry mean.
  • -1.0% Return on Equity means Hwail generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is -1.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM0.5%-1.6%
TTM0.5%YOY-0.9%+1.5%
TTM0.5%5Y0.2%+0.4%
5Y0.2%10Y0.7%-0.5%

1.2. Operating Efficiency of Hwail Pharmaceutical Co.Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hwail is operating .

  • Measures how much profit Hwail makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hwail to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.3%-0.3%
1.2.2. Operating Ratio

Measures how efficient Hwail is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ₩1.88 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 1.877. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.873. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.877TTM1.873+0.004
TTM1.873YOY1.154+0.718
TTM1.8735Y1.165+0.707
5Y1.16510Y1.164+0.001

1.3. Liquidity of Hwail Pharmaceutical Co.Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hwail is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 12.39 means the company has ₩12.39 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 12.392. The company is very able to pay all its short-term debts. +2
  • The TTM is 14.071. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.392TTM14.071-1.679
TTM14.071YOY13.815+0.256
TTM14.0715Y10.223+3.847
5Y10.22310Y6.406+3.817
1.3.2. Quick Ratio

Measures if Hwail is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hwail to the  industry mean.
  • A Quick Ratio of 2.71 means the company can pay off ₩2.71 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 2.714. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.619. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.714TTM6.619-3.905
TTM6.619YOY14.355-7.736
TTM6.6195Y7.711-1.092
5Y7.71110Y5.181+2.530

1.4. Solvency of Hwail Pharmaceutical Co.Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hwail assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hwail to industry mean.
  • A Debt to Asset Ratio of 0.06 means that Hwail assets are financed with 6.2% credit (debt) and the remaining percentage (100% - 6.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.056. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.056+0.006
TTM0.056YOY0.061-0.005
TTM0.0565Y0.084-0.028
5Y0.08410Y0.163-0.079
1.4.2. Debt to Equity Ratio

Measures if Hwail is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hwail to the  industry mean.
  • A Debt to Equity ratio of 6.6% means that company has ₩0.07 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The MRQ is 0.066. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.059. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.059+0.007
TTM0.059YOY0.065-0.006
TTM0.0595Y0.094-0.035
5Y0.09410Y0.211-0.118

2. Market Valuation of Hwail Pharmaceutical Co.Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Hwail generates.

  • Above 15 is considered overpriced but always compare Hwail to the  industry mean.
  • A PE ratio of -19.46 means the investor is paying ₩-19.46 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The EOD is -14.131. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.462. Based on the earnings, the company is expensive. -2
  • The TTM is 15.287. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-14.131MRQ-19.462+5.331
MRQ-19.462TTM15.287-34.749
TTM15.287YOY8.375+6.912
TTM15.2875Y49.762-34.475
5Y49.76210Y75.127-25.365
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The EOD is 2.622. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.611. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -1.028. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.622MRQ3.611-0.989
MRQ3.611TTM-1.028+4.639
TTM-1.028YOY0.297-1.325
TTM-1.0285Y0.451-1.479
5Y0.45110Y-10.454+10.905
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hwail is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.81 means the investor is paying ₩0.81 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Hwail Pharmaceutical Co.Ltd:

  • The EOD is 0.590. Based on the equity, the company is cheap. +2
  • The MRQ is 0.813. Based on the equity, the company is cheap. +2
  • The TTM is 0.779. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.590MRQ0.813-0.223
MRQ0.813TTM0.779+0.033
TTM0.779YOY0.996-0.217
TTM0.7795Y2.296-1.517
5Y2.29610Y3.403-1.107
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hwail Pharmaceutical Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---31.34818.737-267%-32.215+3%65.929-148%44.171-171%
Book Value Per Share--2713.8452696.657+1%2733.729-1%2476.530+10%2051.244+32%
Current Ratio--12.39214.071-12%13.815-10%10.223+21%6.406+93%
Debt To Asset Ratio--0.0620.056+11%0.061+2%0.084-26%0.163-62%
Debt To Equity Ratio--0.0660.059+12%0.065+2%0.094-30%0.211-69%
Dividend Per Share----0%-0%8.835-100%10.227-100%
Eps---28.32414.757-292%-23.939-15%3.664-873%10.596-367%
Free Cash Flow Per Share--152.66120.499+645%-12.055+108%11.292+1252%16.382+832%
Free Cash Flow To Equity Per Share--152.66120.210+655%-24.031+116%129.203+18%97.103+57%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14941.837--------
Intrinsic Value_10Y_min--12489.915--------
Intrinsic Value_1Y_max--426.346--------
Intrinsic Value_1Y_min--418.145--------
Intrinsic Value_3Y_max--2097.170--------
Intrinsic Value_3Y_min--1985.655--------
Intrinsic Value_5Y_max--4751.993--------
Intrinsic Value_5Y_min--4340.431--------
Market Cap102772672800.000-38%141743631330.000137383354737.500+3%182548603512.500-22%330311903041.796-57%386422425164.877-63%
Net Profit Margin---0.0620.032-293%-0.051-18%0.008-905%0.024-360%
Operating Margin----0%-0%-0%0.003-100%
Operating Ratio--1.8771.873+0%1.154+63%1.165+61%1.164+61%
Pb Ratio0.590-38%0.8130.779+4%0.996-18%2.296-65%3.403-76%
Pe Ratio-14.131+27%-19.46215.287-227%8.375-332%49.762-139%75.127-126%
Price Per Share1601.000-38%2205.0002101.250+5%2723.750-19%5098.055-57%5992.097-63%
Price To Free Cash Flow Ratio2.622-38%3.611-1.028+128%0.297+1116%0.451+701%-10.454+390%
Price To Total Gains Ratio-51.072+27%-70.33960.535-216%88.639-179%-132.301+88%-65.165-7%
Quick Ratio--2.7146.619-59%14.355-81%7.711-65%5.181-48%
Return On Assets---0.0100.005-289%-0.009-10%0.002-742%0.005-298%
Return On Equity---0.0100.005-292%-0.009-12%0.002-668%0.007-254%
Total Gains Per Share---31.34818.737-267%-32.215+3%74.765-142%54.398-158%
Usd Book Value--122117544.654123441835.493-1%128039037.145-5%113405288.560+8%93404990.894+31%
Usd Book Value Change Per Share---0.0220.013-267%-0.023+3%0.046-148%0.031-171%
Usd Book Value Per Share--1.9001.888+1%1.914-1%1.734+10%1.436+32%
Usd Dividend Per Share----0%-0%0.006-100%0.007-100%
Usd Eps---0.0200.010-292%-0.017-15%0.003-873%0.007-367%
Usd Free Cash Flow--6869434.334861484.572+697%-549563.579+108%527220.815+1203%581436.723+1081%
Usd Free Cash Flow Per Share--0.1070.014+645%-0.008+108%0.008+1252%0.011+832%
Usd Free Cash Flow To Equity Per Share--0.1070.014+655%-0.017+116%0.090+18%0.068+57%
Usd Market Cap71940870.960-38%99220541.93196168348.316+3%127784022.459-22%231218332.129-57%270495697.615-63%
Usd Price Per Share1.121-38%1.5441.471+5%1.907-19%3.569-57%4.194-63%
Usd Profit---1274514.206676067.292-289%-1107218.459-13%162201.681-886%474705.407-368%
Usd Revenue--20531395.12221444713.484-4%23109231.063-11%21135208.765-3%19984969.395+3%
Usd Total Gains Per Share---0.0220.013-267%-0.023+3%0.052-142%0.038-158%
 EOD+4 -4MRQTTM+11 -21YOY+12 -205Y+15 -1910Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of Hwail Pharmaceutical Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.131
Price to Book Ratio (EOD)Between0-10.590
Net Profit Margin (MRQ)Greater than0-0.062
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.714
Current Ratio (MRQ)Greater than112.392
Debt to Asset Ratio (MRQ)Less than10.062
Debt to Equity Ratio (MRQ)Less than10.066
Return on Equity (MRQ)Greater than0.15-0.010
Return on Assets (MRQ)Greater than0.05-0.010
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Hwail Pharmaceutical Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.600
Ma 20Greater thanMa 501,617.800
Ma 50Greater thanMa 1001,674.080
Ma 100Greater thanMa 2001,869.940
OpenGreater thanClose1,580.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets186,001,476
Total Liabilities11,547,841
Total Stockholder Equity174,453,634
 As reported
Total Liabilities 11,547,841
Total Stockholder Equity+ 174,453,634
Total Assets = 186,001,476

Assets

Total Assets186,001,476
Total Current Assets136,628,964
Long-term Assets49,372,513
Total Current Assets
Cash And Cash Equivalents 66,824,713
Short-term Investments 5,019,665
Net Receivables 24,900,692
Inventory 35,510,298
Other Current Assets 189,379
Total Current Assets  (as reported)136,628,964
Total Current Assets  (calculated)132,444,747
+/- 4,184,216
Long-term Assets
Property Plant Equipment 32,926,785
Intangible Assets 1,845,880
Long-term Assets Other 0
Long-term Assets  (as reported)49,372,513
Long-term Assets  (calculated)34,772,665
+/- 14,599,847

Liabilities & Shareholders' Equity

Total Current Liabilities11,025,895
Long-term Liabilities521,946
Total Stockholder Equity174,453,634
Total Current Liabilities
Short Long Term Debt 2,000,000
Accounts payable 4,003,873
Other Current Liabilities 209,228
Total Current Liabilities  (as reported)11,025,895
Total Current Liabilities  (calculated)6,213,102
+/- 4,812,794
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt339,350
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)521,946
Long-term Liabilities  (calculated)339,351
+/- 182,595
Total Stockholder Equity
Retained Earnings 77,371,613
Total Stockholder Equity (as reported)174,453,634
Total Stockholder Equity (calculated)77,371,613
+/- 97,082,022
Other
Capital Stock34,026,003
Common Stock Shares Outstanding 64,283
Net Invested Capital 176,453,634
Net Working Capital 125,603,068
Property Plant and Equipment Gross 32,926,785



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
116,282,861
126,837,831
121,986,024
123,024,132
122,588,270
121,572,203
119,568,863
122,924,472
123,622,844
121,698,823
128,894,546
140,271,903
143,524,261
139,529,701
134,748,639
128,615,736
127,962,699
120,925,760
139,400,638
144,953,831
140,306,500
153,830,686
169,676,277
191,847,564
192,599,565
192,882,951
194,146,674
202,918,928
200,340,653
190,580,661
185,597,115
185,597,300
189,423,259
185,987,194
186,001,476
186,001,476185,987,194189,423,259185,597,300185,597,115190,580,661200,340,653202,918,928194,146,674192,882,951192,599,565191,847,564169,676,277153,830,686140,306,500144,953,831139,400,638120,925,760127,962,699128,615,736134,748,639139,529,701143,524,261140,271,903128,894,546121,698,823123,622,844122,924,472119,568,863121,572,203122,588,270123,024,132121,986,024126,837,831116,282,861
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
85,107,158
80,191,616
76,123,676
77,082,082
77,559,247
95,767,144
100,741,040
96,207,892
108,715,667
106,394,846
98,011,402
115,797,921
94,775,393
148,833,400
152,617,328
154,684,053
143,819,579
138,067,562
131,621,873
135,046,624
134,031,204
136,628,964
136,628,964134,031,204135,046,624131,621,873138,067,562143,819,579154,684,053152,617,328148,833,40094,775,393115,797,92198,011,402106,394,846108,715,66796,207,892100,741,04095,767,14477,559,24777,082,08276,123,67680,191,61685,107,1580000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,213,471
7,454,347
8,304,305
9,398,946
8,811,659
27,291,980
8,295,291
9,484,049
28,176,889
34,343,526
27,363,126
954
901
673
611
548
503
438
7,572
340
56,248,477
66,824,713
66,824,71356,248,4773407,57243850354861167390195427,363,12634,343,52628,176,8899,484,0498,295,29127,291,9808,811,6599,398,9468,304,3057,454,3479,213,4710000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,588,255
4,165,301
1,743,311
2,431,906
0
0
0
0
5,571,842
3,347,506
7,008,696
0
0
50,076,688
45,188,433
45,322,971
35,124,791
30,299,496
5,000,000
5,000,000
5,203,322
5,019,665
5,019,6655,203,3225,000,0005,000,00030,299,49635,124,79145,322,97145,188,43350,076,688007,008,6963,347,5065,571,84200002,431,9061,743,3114,165,3013,588,2550000000000000
       Net Receivables 
40,866,174
45,562,556
36,952,535
31,951,955
34,768,656
35,880,666
34,162,327
38,102,032
37,279,390
36,535,085
41,104,183
42,156,813
44,950,811
44,238,407
43,657,838
41,077,949
41,736,146
34,481,144
36,321,408
45,301,964
43,558,387
39,189,671
29,773,539
28,797,381
28,205,130
25,462,019
28,469,988
28,300,455
32,772,017
28,920,418
28,556,283
27,394,291
28,906,471
29,293,315
24,900,692
24,900,69229,293,31528,906,47127,394,29128,556,28328,920,41832,772,01728,300,45528,469,98825,462,01928,205,13028,797,38129,773,53939,189,67143,558,38745,301,96436,321,40834,481,14441,736,14641,077,94943,657,83844,238,40744,950,81142,156,81341,104,18336,535,08537,279,39038,102,03234,162,32735,880,66634,768,65631,951,95536,952,53545,562,55640,866,174
       Other Current Assets 
1,247,531
1,056,064
964,503
914,534
4,146,382
978,338
1,006,688
696,662
1,015,177
125,573
150,759
174,540
144,963
89,014
80,001
174,973
65,110
0
0
0
0
0
0
0
0
0
0
0
402,640
389,774
366,259
203,456
202,662
193,293
189,379
189,379193,293202,662203,456366,259389,774402,6400000000000065,110174,97380,00189,014144,963174,540150,759125,5731,015,177696,6621,006,688978,3384,146,382914,534964,5031,056,0641,247,531
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,529,553
53,975,426
54,376,635
51,955,990
49,372,513
49,372,51351,955,99054,376,63553,975,42647,529,553000000000000000000000000000000
       Property Plant Equipment 
32,431,872
36,461,437
38,054,515
38,907,334
39,382,278
39,320,382
39,313,275
39,039,569
38,504,653
38,539,989
38,198,040
37,654,441
37,159,089
36,634,331
36,077,432
35,688,028
35,241,129
31,624,316
31,606,408
32,527,225
33,626,507
34,556,513
34,371,264
34,961,270
29,320,908
30,578,443
30,633,020
30,316,726
30,274,228
31,414,019
31,558,701
31,368,103
31,652,225
31,723,441
32,926,785
32,926,78531,723,44131,652,22531,368,10331,558,70131,414,01930,274,22830,316,72630,633,02030,578,44329,320,90834,961,27034,371,26434,556,51333,626,50732,527,22531,606,40831,624,31635,241,12935,688,02836,077,43236,634,33137,159,08937,654,44138,198,04038,539,98938,504,65339,039,56939,313,27539,320,38239,382,27838,907,33438,054,51536,461,43732,431,872
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,246,681
10,220,526
8,775,402
7,772,324
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000007,772,3248,775,40210,220,5269,246,6810000000000000
       Intangible Assets 
633,893
619,120
604,347
4,189,575
4,144,802
4,225,497
4,180,723
4,812,951
4,734,328
5,166,706
5,088,080
4,835,327
4,694,204
4,553,081
4,411,958
4,170,836
4,031,228
3,398,062
3,263,088
3,161,964
3,060,841
2,959,717
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,789,306
1,847,164
1,847,164
1,845,880
1,845,8801,847,1641,847,1641,789,3061,789,3061,789,3061,789,3061,789,3061,789,3061,789,3061,789,3061,789,3061,789,3062,959,7173,060,8413,161,9643,263,0883,398,0624,031,2284,170,8364,411,9584,553,0814,694,2044,835,3275,088,0805,166,7064,734,3284,812,9514,180,7234,225,4974,144,8024,189,575604,347619,120633,893
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000
> Total Liabilities 
32,479,577
41,286,420
36,010,041
36,714,983
36,571,550
34,225,965
31,544,686
33,854,341
35,143,518
31,934,668
38,810,256
41,327,973
42,693,764
37,740,861
32,616,567
28,755,174
29,932,889
19,093,782
19,970,003
25,733,590
20,207,466
13,279,335
12,816,008
13,395,975
12,634,650
11,848,262
12,488,941
13,767,224
14,156,980
9,837,761
10,023,751
8,754,103
11,806,948
9,518,419
11,547,841
11,547,8419,518,41911,806,9488,754,10310,023,7519,837,76114,156,98013,767,22412,488,94111,848,26212,634,65013,395,97512,816,00813,279,33520,207,46625,733,59019,970,00319,093,78229,932,88928,755,17432,616,56737,740,86142,693,76441,327,97338,810,25631,934,66835,143,51833,854,34131,544,68634,225,96536,571,55036,714,98336,010,04141,286,42032,479,577
   > Total Current Liabilities 
24,467,008
28,366,261
22,443,093
25,392,475
25,690,868
21,233,405
18,890,424
21,861,702
23,390,143
24,975,909
32,229,962
33,490,506
35,769,668
26,359,883
21,666,879
19,168,832
20,974,407
18,852,872
19,752,560
25,525,604
19,995,550
12,824,110
12,362,443
12,971,716
12,228,055
11,390,484
12,071,271
13,355,905
13,765,591
9,456,919
7,940,869
7,784,734
11,222,319
8,965,328
11,025,895
11,025,8958,965,32811,222,3197,784,7347,940,8699,456,91913,765,59113,355,90512,071,27111,390,48412,228,05512,971,71612,362,44312,824,11019,995,55025,525,60419,752,56018,852,87220,974,40719,168,83221,666,87926,359,88335,769,66833,490,50632,229,96224,975,90923,390,14321,861,70218,890,42421,233,40525,690,86825,392,47522,443,09328,366,26124,467,008
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,354,840
1,354,840
1,354,840
1,354,840
6,378,868
6,042,799
8,041,983
6,026,630
6,029,707
6,360,195
6,000,000
6,000,000
6,000,000
6,000,000
6,000,000
6,000,000
2,000,000
2,000,000
2,000,000
2,000,000
0
0
002,000,0002,000,0002,000,0002,000,0006,000,0006,000,0006,000,0006,000,0006,000,0006,000,0006,360,1956,029,7076,026,6308,041,9836,042,7996,378,8681,354,8401,354,8401,354,8401,354,8400000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,354,840
1,354,840
1,354,840
1,354,840
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000,000
2,000,000
2,000,000
2,000,000
2,000,000
2,000,0002,000,0002,000,0002,000,0002,000,00000000000000001,354,8401,354,8401,354,8401,354,8400000000000000
       Accounts payable 
7,473,048
6,894,674
4,636,368
5,105,213
6,777,511
6,027,756
7,437,749
6,777,041
6,547,515
8,014,785
6,177,227
6,476,448
6,198,628
6,762,894
5,294,343
5,755,348
4,957,343
0
0
0
0
0
0
0
0
0
0
0
0
0
3,494,813
3,731,670
5,636,016
3,777,105
4,003,873
4,003,8733,777,1055,636,0163,731,6703,494,81300000000000004,957,3435,755,3485,294,3436,762,8946,198,6286,476,4486,177,2278,014,7856,547,5156,777,0417,437,7496,027,7566,777,5115,105,2134,636,3686,894,6747,473,048
       Other Current Liabilities 
4,158,976
3,952,223
3,331,752
8,360,376
6,519,625
2,155,916
2,001,779
1,857,011
3,195,272
4,092,598
4,410,599
5,280,080
8,630,410
4,119,963
3,834,484
3,302,131
4,799,601
0
0
0
0
0
0
0
0
0
0
0
0
0
407,703
226,965
225,338
213,131
209,228
209,228213,131225,338226,965407,70300000000000004,799,6013,302,1313,834,4844,119,9638,630,4105,280,0804,410,5994,092,5983,195,2721,857,0112,001,7792,155,9166,519,6258,360,3763,331,7523,952,2234,158,976
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,082,883
969,369
584,629
553,092
521,946
521,946553,092584,629969,3692,082,883000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
231,429
217,443
207,986
211,916
181,324
183,565
154,259
136,595
187,778
147,670
141,319
121,389
123,260
124,408
105,666
272,711
0
0
00272,711105,666124,408123,260121,389141,319147,670187,778136,595154,259183,565181,324211,916207,986217,443231,42900000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,354,840
-1,354,840
-1,354,840
-1,354,840
-6,378,868
-6,042,799
-8,041,983
-6,026,630
-6,029,707
-6,360,195
-6,000,000
-6,000,000
-6,000,000
-6,000,000
-6,000,000
-6,000,000
-2,000,000
-1,787,842
-1,812,435
-1,591,721
373,924
339,350
339,350373,924-1,591,721-1,812,435-1,787,842-2,000,000-6,000,000-6,000,000-6,000,000-6,000,000-6,000,000-6,000,000-6,360,195-6,029,707-6,026,630-8,041,983-6,042,799-6,378,868-1,354,840-1,354,840-1,354,840-1,354,8400000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
10011000000000000000000000000000000
> Total Stockholder Equity
83,803,284
85,551,411
85,975,982
86,309,149
86,016,720
87,346,238
88,024,177
89,070,132
88,479,325
89,764,155
90,084,291
98,943,930
100,830,498
101,788,840
102,132,072
99,860,562
98,029,809
101,831,978
119,430,635
119,220,241
120,099,034
140,551,351
156,860,270
178,451,589
179,964,915
181,034,688
181,657,733
189,151,705
186,183,673
180,742,899
175,573,364
176,843,197
177,616,310
176,468,774
174,453,634
174,453,634176,468,774177,616,310176,843,197175,573,364180,742,899186,183,673189,151,705181,657,733181,034,688179,964,915178,451,589156,860,270140,551,351120,099,034119,220,241119,430,635101,831,97898,029,80999,860,562102,132,072101,788,840100,830,49898,943,93090,084,29189,764,15588,479,32589,070,13288,024,17787,346,23886,016,72086,309,14985,975,98285,551,41183,803,284
   Common Stock
7,205,479
7,205,479
7,205,480
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
7,205,479
8,646,575
8,646,575
8,650,625
9,650,625
10,434,326
32,802,977
32,816,777
32,816,777
32,816,777
34,007,253
34,026,003
34,026,003
34,026,003
34,026,003
34,026,003
0
0
0034,026,00334,026,00334,026,00334,026,00334,026,00334,007,25332,816,77732,816,77732,816,77732,802,97710,434,3269,650,6258,650,6258,646,5758,646,5757,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4797,205,4807,205,4797,205,479
   Retained Earnings Total Equity00000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,625,046
35,191,491
35,191,844
35,256,993
54,290,068
70,014,896
58,914,552
58,985,565
58,985,565
58,985,565
62,785,668
62,870,349
62,870,350
62,870,349
62,870,349
62,870,349
0
0
0062,870,34962,870,34962,870,34962,870,35062,870,34962,785,66858,985,56558,985,56558,985,56558,914,55270,014,89654,290,06835,256,99335,191,84435,191,49119,625,04600000000000000000
   Treasury Stock000000000000-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509-6,477,509
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,792,550
2,620,738
2,304,861
1,617,237
2,081,001
2,081,001
2,081,002
2,081,001
2,081,536
2,081,536
5,064,219
5,064,754
5,064,754
5,063,684
5,063,684
5,063,684
5,063,684
5,063,684
5,063,684
5,063,684
0
0
005,063,6845,063,6845,063,6845,063,6845,063,6845,063,6845,063,6845,064,7545,064,7545,064,2192,081,5362,081,5362,081,0012,081,0022,081,0012,081,0011,617,2372,304,8612,620,7382,792,5500000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue122,541,220
Cost of Revenue-111,022,619
Gross Profit11,518,60111,518,601
 
Operating Income (+$)
Gross Profit11,518,601
Operating Expense-120,493,815
Operating Income2,047,405-108,975,214
 
Operating Expense (+$)
Research Development670,021
Selling General Administrative2,052,389
Selling And Marketing Expenses0
Operating Expense120,493,8152,722,410
 
Net Interest Income (+$)
Interest Income1,700,901
Interest Expense-18,942
Other Finance Cost-1
Net Interest Income1,681,958
 
Pretax Income (+$)
Operating Income2,047,405
Net Interest Income1,681,958
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,898,1632,047,405
EBIT - interestExpense = -18,942
3,863,242
3,882,184
Interest Expense18,942
Earnings Before Interest and Taxes (EBIT)04,917,105
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax4,898,163
Tax Provision-1,034,921
Net Income From Continuing Ops3,863,2423,863,242
Net Income3,863,242
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,681,958
 

Technical Analysis of Hwail
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hwail. The general trend of Hwail is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hwail's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hwail Pharmaceutical Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1,599 < 1,612 < 1,621.

The bearish price targets are: 1,551 > 1,550.

Tweet this
Hwail Pharmaceutical Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hwail Pharmaceutical Co.Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hwail Pharmaceutical Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hwail Pharmaceutical Co.Ltd. The current macd is -28.16003281.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hwail price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hwail. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hwail price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hwail Pharmaceutical Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHwail Pharmaceutical Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hwail Pharmaceutical Co.Ltd. The current adx is 20.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hwail shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hwail Pharmaceutical Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hwail Pharmaceutical Co.Ltd. The current sar is 1,551.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hwail Pharmaceutical Co.Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hwail Pharmaceutical Co.Ltd. The current rsi is 43.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Hwail Pharmaceutical Co.Ltd Daily Relative Strength Index (RSI) ChartHwail Pharmaceutical Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hwail Pharmaceutical Co.Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hwail price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hwail Pharmaceutical Co.Ltd Daily Stochastic Oscillator ChartHwail Pharmaceutical Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hwail Pharmaceutical Co.Ltd. The current cci is -30.63575979.

Hwail Pharmaceutical Co.Ltd Daily Commodity Channel Index (CCI) ChartHwail Pharmaceutical Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hwail Pharmaceutical Co.Ltd. The current cmo is -6.38288094.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hwail Pharmaceutical Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartHwail Pharmaceutical Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hwail Pharmaceutical Co.Ltd. The current willr is -43.18181818.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hwail is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hwail Pharmaceutical Co.Ltd Daily Williams %R ChartHwail Pharmaceutical Co.Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hwail Pharmaceutical Co.Ltd.

Hwail Pharmaceutical Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hwail Pharmaceutical Co.Ltd. The current atr is 37.70.

Hwail Pharmaceutical Co.Ltd Daily Average True Range (ATR) ChartHwail Pharmaceutical Co.Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hwail Pharmaceutical Co.Ltd. The current obv is 428,668,232.

Hwail Pharmaceutical Co.Ltd Daily On-Balance Volume (OBV) ChartHwail Pharmaceutical Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hwail Pharmaceutical Co.Ltd. The current mfi is 35.64.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hwail Pharmaceutical Co.Ltd Daily Money Flow Index (MFI) ChartHwail Pharmaceutical Co.Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hwail Pharmaceutical Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Hwail Pharmaceutical Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hwail Pharmaceutical Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.600
Ma 20Greater thanMa 501,617.800
Ma 50Greater thanMa 1001,674.080
Ma 100Greater thanMa 2001,869.940
OpenGreater thanClose1,580.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hwail with someone you think should read this too:
  • Are you bullish or bearish on Hwail? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hwail? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hwail Pharmaceutical Co.Ltd

I send you an email if I find something interesting about Hwail Pharmaceutical Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hwail Pharmaceutical Co.Ltd.

Receive notifications about Hwail Pharmaceutical Co.Ltd in your mailbox!